Emerging Infectious Diseases (Nov 2007)

Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections

  • Adam L. Cohen,
  • Carrie Shuler,
  • Sigrid McAllister,
  • Gregory E. Fosheim,
  • Michael G. Brown,
  • Debra Abercrombie,
  • Karen F. Anderson,
  • Linda K. McDougal,
  • Cherie L. Drenzek,
  • Katie Arnold,
  • Daniel B. Jernigan,
  • Rachel Gorwitz

DOI
https://doi.org/10.3201/eid1311.070148
Journal volume & issue
Vol. 13, no. 11
pp. 1707 – 1713

Abstract

Read online

Methicillin-resistant Staphylococcus aureus (MRSA) infections and methamphetamine use are emerging public health problems. We conducted a case–control investigation to determine risk factors for MRSA skin and soft tissue infections (SSTIs) in residents of a largely rural southeastern community in the United States. Case-patients were persons >12 years old who had culturable SSTIs; controls had no SSTIs. Of 119 SSTIs identified, 81 (68.1%) were caused by MRSA. Methamphetamine use was reported in 9.9% of case-patients and 1.8% of controls. After we adjusted for age, sex, and race, patients with MRSA SSTIs were more likely than controls to have recently used methamphetamine (odds ratio 5.10, 95% confidence interval 1.55–16.79). MRSA caused most SSTIs in this population. Transmission of MRSA may be occurring among methamphetamine users in this community.

Keywords